This inventor holds 3 USPTO granted patents. Top assignee: University of Southern California. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Innovations in Bone Regeneration: The Work of Jay R Lieberman
Introduction
Jay R Lieberman is a prominent inventor based in Los Angeles, CA, known for his significant contributions to the field of bone regeneration. With a total of two patents to his name, Lieberman has focused on developing innovative methods that enhance the healing process of bone defects.
Latest Patents
Lieberman's latest patents include groundbreaking technologies such as the "Growth factor transduced cell-loaded ceramic scaffold for bone regeneration and repair." This invention discloses methods of regional gene therapy using growth-factor transduced cells in bone graft scenarios. The methods involve the use of 3D printed scaffolds that facilitate the delivery of essential growth factors to promote bone formation. Another patent outlines a method for repairing a bone defect in a patient, which includes providing a ceramic scaffold designed to fill the defect, loading it with growth factor transduced cells, and stabilizing the scaffold until the defect heals.
Career Highlights
Lieberman is affiliated with the University of Southern California, where he continues to advance research in regenerative medicine. His work has garnered attention for its potential to revolutionize treatments for patients with bone injuries.
Collaborations
Lieberman has collaborated with notable colleagues such as William Pannell and Yong Qin Chen, contributing to the advancement of innovative solutions in the field of bone repair.
Conclusion
Jay R Lieberman's contributions to bone regeneration through his innovative patents highlight the importance of research and development in medical technology. His work not only showcases his expertise but also promises to improve patient outcomes in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
